Clinical Trials Logo
  1. Home
  2. Pneumonia
  3. NCT02738645
  4. Details
NCT02738645 Clinical Trial

A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit

Pneumonia Clinical Trial

Official title:
A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02738645
Other study ID # Pneumonia RICU
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 2016
Est. completion date December 2024

Study information
Verified date March 2024
Source Beijing Chao Yang Hospital
Contact Bing Sun, Dr
Phone 86013911151075
Email ricusunbing@126.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

From 2003 when Severe Acute Respiratory Syndromes (SARS) appeared，many new types of respiratory viruses emerge in endlessly. Therefore, the epidemiology and the clinical character has changed quietly, especially severe pneumonia. This cohort study aim to obtain the contents of severe pneumonia patients in Respiratory Intensive Care Unit (RICU). Through the clinical data analysis, the investigators could get the information of the pneumonia caused by different reasons, such as morbidity and mortality, risk factors, clinical symptoms and radiographic changes, the respiratory support parameter and so on. The investigators hope the result could guide them do the clinical work of severe pneumonia better in the future.

Recruitment information / eligibility
Status Recruiting
Enrollment 800
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - admit in RICU because of pneumonia of any causes - anticipated length of hospital stay more than 72h Exclusion Criteria: - admit in RICU because of other causes except pneumonia - do not agree to join this study - admit in RICU for the second time - anticipated length of hospital stay less than 72h

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• pneumonia

Locations
Country Name City State
China Department of respiratory and critical care medicine,Beijing Chao-yang Hospital Beijing Beijing

Sponsors (1)
Lead Sponsor Collaborator
Beijing Chao Yang Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary the mortality caused by any reasons in RICU one years
Primary the morbidity caused by any reasons in RICU one years
Secondary the symptoms description of pneumonia caused by any reasons in RICU all the symptoms caused by pneumonia, such as fever, cough, dyspnea, sputum and so on. The investigators could get the incidence of each of these symptoms. the first 48hours after admitted in RICU
Secondary the respiratory support of pneumonia caused by any reasons in RICU summarize the respiratory support parameters while the patients hospitalized in RICU. For example, the ventilation parameter and mode, Whether the mechanical ventilation complications occurred, and so on. the first 5 days after admitted in RICU
Secondary the treatment options of pneumonia caused by any reasons in RICU the investigators obtain the treatment commons, such as the kind of antibiotics, the dosage of glucocorticoids, etc. 3 weeks
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04244474 - Effect of Vitamin D Supplementation on Improvement of Pneumonic Children Phase 1/Phase 2
Completed NCT05815264 - Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above Phase 1
Recruiting NCT04589936 - Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care N/A
Completed NCT02905383 - The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital N/A
Terminated NCT03944551 - Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa N/A
Completed NCT06210737 - A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years Phase 4
Terminated NCT04660084 - Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT05702788 - Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) Phase 2
Not yet recruiting NCT04171674 - Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation. N/A
Active, not recruiting NCT03140163 - Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR] N/A
Completed NCT02638649 - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Completed NCT02864420 - Hospitalization at Home: The Acute Care Home Hospital Program for Adults N/A
Recruiting NCT02515565 - Physiotherapy in Patients Hospitalized Due to Pneumonia. N/A
Completed NCT02105298 - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study) N/A
Completed NCT01416519 - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation N/A
Completed NCT01446926 - Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Phase 1
Completed NCT01399723 - Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia Phase 3
Terminated NCT02358642 - Drug to Prevent Pneumonia in the Tube Fed Phase 4
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A